Rituxan Approved for Pediatric Patients With Rare Vasculitis Diseases

TUESDAY, Oct. 1, 2019 — Rituxan (rituximab) injection was granted the first approval for a drug to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) in combination with glucocorticoids in children 2 years and older,…
Source: Topamax